Cloverbiopharma
Chengdu · Founded 2018 · 1 known investors
Clover Biopharma is a commercial-stage biotechnology company that develops vaccines using its Trimer-Tag technology platform along with in-house manufacturing and commercial capabilities. Its pipeline focuses on respiratory vaccine candidates, including RSV, hMPV, and PIV3 combinations, for populations worldwide.
Founders & leadership
Cloverbiopharma was founded in 2018 by Peng Liang.
PL
Peng LiangFounder
JL
Joshua LiangExecutive
Board
XW
Xiaodong WangBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$53.4M disclosed across 3 rounds · 2021–2026
▶$3.6MraisedApr 2026 · 9 investors · BiotechnologyRule 506(b)
▶$3.6MraisedApr 2026 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peng LiangExecutive Officer, Director, Promoter
- Joshua LiangExecutive Officer, Director
- Xiaodong WangDirector
- Offering amount
- $3.6M
- Amount sold
- $3.6M
- First sale
- Mar 2026
- Incorporated
- Corporation, Cayman Islands
- Federal exemptions
- 06b
▶$904.9KraisedApr 2025 · 13 investors · BiotechnologyRule 506(b)
▶$904.9KraisedApr 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joshua LiangExecutive Officer, Director
- Peng LiangExecutive Officer, Director, Promoter
- Xiaodong WangDirector
- Offering amount
- $904.9K
- Amount sold
- $904.9K
- First sale
- Apr 2024
- Incorporated
- Corporation, Cayman Islands
- Federal exemptions
- 06b
▶$48.9MraisedMay 2023 · 74 investors · BiotechnologyRule 506(b)
▶$48.9MraisedMay 2023 · 74 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peng LiangExecutive Officer, Director, Promoter
- Xiaodong WangDirector
- Joshua LiangExecutive Officer, Director
- Amount sold
- $48.9M
- First sale
- Apr 2021
- Incorporated
- Corporation, Cayman Islands, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Clover Health5 shared keywordsClover Health is a health insurance provider offering low-cost plans with minimal premiums, copays, and prescription drug costs. The company uses technology called Clover Assistant to help members focus on healthier living.
Vir4 shared keywordsVir Biotechnology develops treatments for infectious diseases and oncology, leveraging immunology-focused scientific capabilities. The company targets patients with unmet medical needs across these therapeutic areas.
Dynavax NASDAQ: DVAX www.dynavax.com3 shared keywordsDynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology. Its products target immunization and infectious disease prevention.
IconOVir Bio3 shared keywordsIconovir is a biotechnology company focused on developing cancer treatments, with a stated mission to cure cancer and restore life to patients.
Companies competing with Cloverbiopharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cloverbiopharma do?
- Clover Biopharma is a commercial-stage biotechnology company that develops vaccines using its Trimer-Tag technology platform along with in-house manufacturing and commercial capabilities. Its pipeline focuses on respiratory vaccine candidates, including RSV, hMPV, and PIV3 combinations, for populations worldwide.
- Who founded Cloverbiopharma?
- Cloverbiopharma was founded by Peng Liang in 2018.
- Who are Cloverbiopharma's investors?
- Cloverbiopharma's investors include Delos Capital.
- How much funding has Cloverbiopharma raised?
- Cloverbiopharma has disclosed $53.4M raised across 3 rounds.
- Where is Cloverbiopharma headquartered?
- Cloverbiopharma is headquartered in Chengdu.